Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

Despite advances in immunosuppressive drugs, long-term success of liver transplantation is still limited by the development of chronic liver allograft dysfunction. Although the exact pathogenesis of chronic liver allograft dysfunction remains to be established, there is strong evidence that chemokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Li, Jing, Yan, Lu-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870628/
https://www.ncbi.nlm.nih.gov/pubmed/24382971
http://dx.doi.org/10.1155/2013/325318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870628/
https://www.ncbi.nlm.nih.gov/pubmed/24382971
http://dx.doi.org/10.1155/2013/325318

Ejemplares similares